COPD & Asthma Flashcards

1
Q

What is Asthma?

A
  • chronic inflammatory disease of resp tract
  • airway hyper-responsiveness
  • Symptoms: wheezing, SOB, chest tightness, cough. bronchoconstriction and thickened bronchial wall and increased mucus secretion

Often worsened by: cigarette smoke, exercise, stress and certain medications e.g. aspirin or beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the asthma phenotypes?

A
  • Allergic asthma: most common- associated with childhood, family history etc
  • Non allergic asthma
  • Adult onset asthma
  • Asthma with persistent airflow limitation
  • Asthma with obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is asthma controlled?

A
  • control asthma symptoms
  • prevent future risk and exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is asthma severity assessed? What type drugs are used for each type?

A
  • mild: Step 1 or 2
  • Step 1: low dose ICS
  • Step 2: low dose ICS plus SABA
  • moderate: Step 3
  • low dose ICS and LABA
  • severe: Step 4 or 5
  • high dose ICS and LABA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What may be possible reasons for uncontrolled symptoms and/or exacerbations despite 2-3 months of controller treatment?

A
  • incorrect inhaler usage
  • poor adherence
  • persistent exposure to allergens, tobacco smoke, air pollution etc.
  • other comorbidities
  • incorrect diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the medical categories for treatment of asthma?

A
  • controller medication: reduce airway inflammation, control symptoms and reduce risk of exacerbation or decline in lung function
  • Reliever medication: relief of breakthrough symptoms, also during worsening asthma or exacerbation
  • Add on therapy for severe asthma: persistent symptoms and/or exacerbations despite optimised therapy with high dose controller medications (Step 4 or 5)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What points are important to consider when starting asthma therapy?

A
  • goal of administering lowest effective dose of ICS to provide satisfactory therapeutic response
  • correct monitoring of patient to identify correct dose
  • ICS are initial therapy for symptom control in elderly patients and adolescents
  • either in combo with LABA or alone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Stepping Up Treatment in Asthma?

A
  • Sustained step up: 2-3 months increased maintenance dose to medium dosage
  • Short term step up: 1-2 weeks increased maintenance ICS dosage during viral infection or seasonal allergen exposure
  • Day to day: according to patient symptoms doses may be adjusted while continuing maintenance dosage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Stepping Down Treatment in Asthma?

A
  • Once asthma is well controlled and maintained for 3 months and lung function has reached plateau, treatment can be reduced

Stepping down to:
- find patients minimum effective treatment
- maintain good control of symptoms and exacerbations
- minimize costs of treatment and possible adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is COPD?

A
  • preventable and treatable disease
  • persistent respiratory symptoms and airflow limitations due to airway and/or alveolar abnormalities due to exposure to gases or noxious particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference in pharmacotherapy approach in asthma and COPD?

A

Asthma:
- ICS either alone or in combo with LABA
- NOT recommended to use LABA/LAMA alone

COPD:
- LABA/LAMA with as-needed SABA (WITHOUT ICS)

Both Asthma & COPD:
- treat as asthma
- ICS containing therapy to reduce risk of exacerbations
- not recommended to use LABA or LAMA alone without ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is it essential to use ICS in asthma?

A
  • ICS formoterol or SABA
  • ICS formoterol is preferred reliever due to reduced risk of serious exacerbations
  • research suggests not to use SABA w/o ICS- does not protect against exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are ICS? MOA? AE? Contraindications?

A

e.g.
In combo with LABA:
- beclamethasone, budesonide (both combined with formoterol)
- fluticasone-salmeterol
- mometasone - formoterol

MOA: inhibit release of arachidonic acid through inhibition of phospholipase A2- anti inflammatory function

AE: not many experience AE’s- oropharyngeal candidiasis and dysphonia : can be reduced with the use of a spacer
* long term usage- increased risk of osteoporosis, cataract and glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why use LABA with ICS?

A
  • low dose of ICS alone fails to achieve good control of asthma
  • LABA combo improves ICS symptoms, lung function and reduces exacerbation in more patients, more rapidly than x2ing the dose of ICS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 2 regimens available for ICS combination with LABA?

A

1) low dose beclamethasone or budesonide with low dose formoterol (for maintenance and reliever treatment- MART)

2) Maintenance ICS-LABA with SABA as reliever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are LABA AE?

A
  • tachycardia, headache or cramps
  • LABA should not be used alone in asthma due to increased risk of adverse effects
17
Q

What are leukotriene modifiers (leukotriene receptor antagonist- LTRA)? AE?

A
  • Montelukast, zafirlukast, pranlukast
  • less effective than ICS in monotherapy
  • less effective than ICS-LABA with put in combo with ICS

AE: elevated liver function tests (zilueton and zafirlukast)

18
Q

What Long acting muscarinic antagonists (LAMA) are used in add-on controller medication for maintenance treatment?

A
  • tiotropium
  • glycopyrronium
  • umeclidinium

*add on at Step 5 for patient with uncontrolled asthma despite ICS-LABA

19
Q

What anti-IgE are used in add-on controller medication for maintenance treatment?

A
  • Omalizumab
  • in patients older than 6
  • add on for severe allergic asthma, uncontrolled despite high dose ICS-LABA
20
Q

What anti- IL5 & anti- IL5R are used in add-on controller medication for maintenance treatment?

A
  • anti-IL5: mepolizumab
  • subcutaneous older than 6
  • reslizumab IV for patients > 18
  • anti-IL5R: benralizumab
  • subcutaneous in patients > 12 in severe persistent eosinophilic asthma

*add on option for patients with severe eosinophilic asthma, uncontrolled despite high dose ICS-LABA

21
Q

What anti- IL4R are used in add-on controller medication for maintenance treatment?

A

-DUPLIMAB
- subcutaneous in patients > 6

*add on option for patients with severe eosinophilic asthma, uncontrolled despite high dose ICS-LABA

22
Q

What systemic corticosteroids are used in add-on controller medication for maintenance treatment?

A
  • prednisolone, prednisone, methyprednisolone, dexamethasone & hydrocortisone
  • short term treatment (5-7 days) key for severe acute exacerbations with main effects seen after 4-6 hours
  • effective preventing relapse OCS
  • as last resort, patients with long term treatment with OCS may be required for some severe asthma patients
23
Q

What are the AE of OCS?

A
  • short course: sepsis, thromboembolism, sleep disturbance, reflux, hyperglycemia

maintenance use: cataract. glaucoma, diabetes, hypertension, adrenal suppression and osteoporosis

24
Q

What are SABA? Use? AE?

A
  • short acting inhaled beta-2 agonist bronchodilators
  • e.g. salbutamol, terbutaline
  • provide quick relief of asthma symptoms and bronchoconstriction
  • should only be used for “as needed” basis and at lowest dose and frequency required
  • SABA ONLY treatment no recommended due to severe exacerbation risks

AE: tremor, tachycardia

  • tolerance develops rapidly within 1-2 weeks of regular use